Institut de cancérologie Strasbourg Europe
Institut de cancérologie Strasbourg Europe
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology | childhood malignant neoplasm, injury, neoplasm, radiation injury | Recruiting | Not applicable | 2024-11-22 | NCT06033183 | |
| Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients | Hypoxia, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 3 | 2024-06-27 | NCT06477939 | |
| Thero2-01S22 in HER2-positive Breast Cancer | HER2-positive Breast Cancer | Not yet recruiting | Phase 3 | 2023-01-26 | NCT05698186 | |
| Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) | HER2-positive Breast Cancer | Not yet recruiting | Phase 3 | 2022-05-27 | NCT05388500 |